Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Pharmacogenomics.

Jeffrey S Ross1, David P Schenkein, Oscar Kashala

  • 1Division of Molecular Medicine, Millennium Pharmaceuticals, Inc, Cambridge, Massachusetts, USA. rossj@mail.amc.edu

Advances in Anatomic Pathology
|June 29, 2004
PubMed
Summary

Advances in genomics and proteomics are revolutionizing healthcare by enabling personalized medicine. Pharmacogenomics uses genetic information to predict individual drug responses, improving treatment efficacy and reducing toxicity.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

IDH2 mutation-induced histone and DNA hypermethylation is progressively reversed by small-molecule inhibition.

Blood·2014
Same author

Isocitrate dehydrogenase 1 (IDH1) mutation in breast adenocarcinoma is associated with elevated levels of serum and urine 2-hydroxyglutarate.

The oncologist·2014
Same author

Circulating oncometabolite 2-hydroxyglutarate is a potential surrogate biomarker in patients with isocitrate dehydrogenase-mutant intrahepatic cholangiocarcinoma.

Clinical cancer research : an official journal of the American Association for Cancer Research·2014
Same author

Breast cancer multifocality and multicentricity and locoregional recurrence.

The oncologist·2013
Same author

Trastuzumab-related cardiotoxicity among older patients with breast cancer.

Journal of clinical oncology : official journal of the American Society of Clinical Oncology·2013
Same author

DNA repair gene patterns as prognostic and predictive factors in molecular breast cancer subtypes.

The oncologist·2013

Area of Science:

  • Genomic Medicine
  • Molecular Biology
  • Computational Biology

Background:

  • Human genome discovery and proteomics research are transforming healthcare.
  • Gene expression patterns guide therapy for cancer and other diseases like inflammatory, cardiovascular, and neurodegenerative disorders.
  • Pharmacogenetics and pharmacogenomics offer new platforms for individualized patient management.

Purpose of the Study:

  • To explore the role of pharmacogenomics in predicting drug efficacy and toxicity.
  • To highlight the application of genomic technologies in personalized medicine.
  • To discuss the impact of gene expression analysis on disease classification and treatment selection.

Main Methods:

  • Utilizing functional imaging, biosensors, and computational biology.

Related Experiment Videos

  • Analyzing genetic variants in drug targets, disease pathways, and drug-metabolizing enzymes.
  • Employing SNP technology for cancer predisposition and drug response prediction.
  • Applying whole genome technologies like genomic microarrays and transcriptional profiling.

    • Main Results:

    • Gene expression differences can guide therapy for various conditions.
    • Genetic variants predict drug efficacy and toxicity.
    • Genomic microarrays and transcriptional profiling generate vast datasets for analysis.
    • New information is generated for leukemia/lymphoma, solid tumors, metastasis prediction, and drug discovery.

    Conclusions:

    • Pharmacogenomics enables prediction of individual disease sensitivity or resistance to drugs.
    • Sophisticated data analysis is crucial for leveraging genomic data.
    • This approach enhances cancer treatment, drug discovery, and biomarker identification.